Skip to main content
FinSpry Logo
FinSpry
PRVA logo
PRVA
(NASDAQ)
Privia Health Group, Inc.
$23.74-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Privia Health Group, Inc. (PRVA) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Privia Health Group, Inc. stock.

Analyst Consensus Rating

Investment consensus from 10 professional research analysts

Consensus Rating

Buy
Based on 10 unique analysts
High Confidence∞:1 Buy/Sell

Average Price Target

$30.10
↑ 26.79% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest PRVA Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Jailendra Singh
Truist
BuyMaintains
$33.00
Richard Close
Canaccord Genuity
BuyMaintains
$34.00
Andrew Mok CFA
Barclays
HoldMaintains
$25.00 → $24.00
Daniel Grosslight
Citi
BuyMaintains
$32.00
Ryan Langston
TD Cowen
BuyMaintains
$30.00
Jessica Tassan
Piper Sandler
BuyReiterates
$36.00
Sean Dodge
BMO Capital
BuyReiterates
$30.00
Ryan Halsted
RBC Capital
BuyReiterates
$31.00
Elizabeth Anderson
Evercore ISI Group
BuyMaintains
$30.00 → $26.00
Andrew Mok
Barclays
HoldMaintains
$23.00 → $25.00

Frequently Asked Questions

What is the analyst consensus rating for PRVA?

The analyst consensus rating for PRVA is "Buy" based on 10 analyst recommendations.

What is the average price target for PRVA?

The average 12-month price target for PRVA is $30.10, representing an upside of 26.8% from the current price of $23.74.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.